| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 19.13▼ | 11.76▲ | 7.98▲ | 3.81▲ | 3.81▲ |
| MA10 | 19.27▼ | 6.13▲ | 4.24▲ | 1.90▲ | 2.15▲ |
| MA20 | 12.74▲ | 3.32▲ | 2.37▲ | 0.96▲ | 1.83▲ |
| MA50 | 5.41▲ | 1.89▲ | 1.63▲ | 0.90▲ | 3.06▲ |
| MA100 | 3.42▲ | 2.10▲ | 2.03▲ | 1.28▲ | 11.06▲ |
| MA200 | 3.02▲ | 2.17▲ | 2.49▲ | 2.71▲ | 20.34▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.147▲ | 2.225▲ | 1.907▲ | 1.253▲ | 1.281▲ |
| RSI | 93.413▲ | 96.317▲ | 96.528▲ | 98.568▲ | 87.684▲ |
| STOCH | 22.379 | 67.756 | 67.011 | 15.847▼ | 15.851▼ |
| WILL %R | -5.040▲ | -5.037▲ | -5.037▲ | -4.920▲ | -4.920▲ |
| CCI | 27.718 | 152.644▲ | 229.683▲ | 466.667▲ | 452.328▲ |
| ▲ PSAR&MOM | $ATTO PSAR Switch Up + Momentum | Set Alert |
| ▲ RSI&VOL | $ATTO RSI Cross Up and Volume | Set Alert |
| ▲ RSI | $ATTO RSI(14) Crossed Above 70 | Set Alert |
| RSI | $ATTO RSI(14) Crossed Above 50 | Set Alert |
| ▲ RSI | $ATTO RSI(14) Crossed Above 30 | Set Alert |
| ▲ MA | $ATTO MA(20) Crossed Above MA(50) | Set Alert |
| ▲ MACD | $ATTO MACD(12,26,9) Crossed Above Zero | Set Alert |
| MA | $ATTO Price Crossed Above MA(200) | Set Alert |
| MA | $ATTO Price Crossed Above MA(50) | Set Alert |
| MA | $ATTO Price Crossed Above MA(26) | Set Alert |
| MA | $ATTO Price Crossed Above MA(13) | Set Alert |
| MA | $ATTO Price Crossed Above MA(7) | Set Alert |
| ▲ GAP | $ATTO Open Gap Up %5 | Set Alert |
| ▲ GAP | $ATTO Open Gap Up %3 | Set Alert |
| ▲ GAP | $ATTO Open Gap Up %2 | Set Alert |
| ▲ BREAK | $ATTO Price Breaks 60 Days High | Set Alert |
| ▲ BREAK | $ATTO Price Breaks 30 Days High | Set Alert |
| ▲ BREAK | $ATTO Price Breaks 20 Days High | Set Alert |
| ▲ BREAK | $ATTO Price Breaks 10 Days High | Set Alert |
|
Friday, August 07, 2026 12:51 AM
SHANGHAI, Aug. 6, 2026 /PRNewswire/ -- Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, ...
|
|
Wednesday, August 05, 2026 12:00 AM
The CEO described these attobodies as “like Lego pieces” with binding arms built to hit multiple pieces of the same target. While ATTO-1310 hits just one target, Attovia’s pipeline also boasts a ...
|
|
Tuesday, August 04, 2026 01:50 PM
Attovia Therapeutics, Inc. (“Attovia”) (Nasdaq: ATTO), a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet need, today ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/08/26 | 20.01 | 20.02 | 18.96 | 19.035 | 19,435 |
| 25/08/23 | 0.0002 | 0.0002 | 0.0002 | 0.0002 | 211 |
| 24/08/23 | 0.0002 | 0.0002 | 0.0002 | 0.0002 | 1,570 |
| 23/08/23 | 0.0002 | 0.0002 | 0.0002 | 0.0002 | 2,560 |
| 22/08/23 | 0.0002 | 0.0002 | 0.0002 | 0.0002 | 4,265 |
| 18/08/23 | 0.0002 | 0.0002 | 0.0002 | 0.0002 | 0 |
| 17/08/23 | 0.0002 | 0.0002 | 0.0002 | 0.0002 | 7,044 |
| 16/08/23 | 0.0002 | 0.0002 | 0.0002 | 0.0002 | 1,380 |
| 15/08/23 | 0.0002 | 0.0002 | 0.0002 | 0.0002 | 1,565 |
| 14/08/23 | 0.0002 | 0.0002 | 0.0002 | 0.0002 | 417 |
|
|
||||
|
|
||||
|
|